GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » Net Margin %

Benchmark Holdings (LSE:BMK) Net Margin % : -18.84% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Benchmark Holdings's Net Income for the three months ended in Dec. 2023 was £-7.6 Mil. Benchmark Holdings's Revenue for the three months ended in Dec. 2023 was £40.5 Mil. Therefore, Benchmark Holdings's net margin for the quarter that ended in Dec. 2023 was -18.84%.

The historical rank and industry rank for Benchmark Holdings's Net Margin % or its related term are showing as below:

LSE:BMK' s Net Margin % Range Over the Past 10 Years
Min: -67.62   Med: -15.22   Max: -3.72
Current: -18.97


LSE:BMK's Net Margin % is ranked worse than
72.72% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs LSE:BMK: -18.97

Benchmark Holdings Net Margin % Historical Data

The historical data trend for Benchmark Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings Net Margin % Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.62 -31.19 -10.31 -20.35 -13.66

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 -6.44 -15.04 -38.11 -18.84

Competitive Comparison of Benchmark Holdings's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's Net Margin % falls into.



Benchmark Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Benchmark Holdings's Net Margin for the fiscal year that ended in Sep. 2023 is calculated as

Net Margin=Net Income (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-23.146/169.476
=-13.66 %

Benchmark Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-7.627/40.473
=-18.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings  (LSE:BMK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Benchmark Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines